NCT04089618

Brief Summary

MBLM is a holistic therapy for people with mental disorders whose feasibility positive effects on patients with depression have already been demonstrated in clinical application and a piloted study. In the present trial, the feasibility and effect of MBLM on patients with chronic pain will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2019

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 13, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

July 28, 2020

Status Verified

July 1, 2020

Enrollment Period

5 months

First QC Date

September 7, 2019

Last Update Submit

July 27, 2020

Conditions

Keywords

YogaMeditationYoga PhilosophyMantraMind-Body

Outcome Measures

Primary Outcomes (3)

  • Pain VAS

    Visual Analog Scale for Pain

    through study completion, daily for around 3 months

  • Pain medication

    Use of pain medication

    through study completion, daily for around 3 months

  • Well-Being

    The WHO-5 Well-Being Scale (WHO-5; World Health Organisation, 1998)

    through study completion, daily for around 3 months

Secondary Outcomes (5)

  • Emotion Regulation

    through study completion, weekly for around 3 months

  • Body awareness

    through study completion, twice weekly for around 3 months

  • Mind-Wandering

    through study completion, weekly for around 3 months

  • Depression, Anxiety & Stress

    through study completion, weekly for around 3 months

  • Pain Self Efficacy

    through study completion, weekly for around 3 months

Other Outcomes (6)

  • Quality of Life

    at week 0 and week 11

  • Chronic Pain Self-Efficacy

    at week 0 and week 11

  • Distress Tolerance

    at week 0 and week 11

  • +3 more other outcomes

Study Arms (3)

Baseline 10 Days

EXPERIMENTAL

10 days baseline before intervention starts.

Behavioral: MBLM

Baseline 17 Days

EXPERIMENTAL

17 days baseline before intervention starts.

Behavioral: MBLM

Baseline 24 Days

EXPERIMENTAL

24 days baseline before intervention starts.

Behavioral: MBLM

Interventions

MBLMBEHAVIORAL

Complex 8 week Mind-Body program.

Baseline 10 DaysBaseline 17 DaysBaseline 24 Days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatients
  • Current diagnosis of a chronic pain disorder.
  • Over 18 years old.
  • Physically able to perform simple yoga postures and sit for 20 minutes.
  • Have given your written consent to participate in the study.

You may not qualify if:

  • Psychotic symptoms
  • Acute suicidality
  • obsessive-compulsive disorder
  • Cerebro-organic diseases with clinically relevant symptoms
  • Severe multimorbidity
  • Current participation in another meditation or yoga study
  • Regular meditation or yoga practice (\> once a week in the last 6 months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diakoniekliniken Zschadraß

Colditz, Saxony, 04680, Germany

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single Case Research (SCR), also known as single case experimenal design (SCED). This is a reserach methodology using a single unit of analysis and characterized by repeated measures over time.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 7, 2019

First Posted

September 13, 2019

Study Start

September 2, 2019

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

July 28, 2020

Record last verified: 2020-07

Locations